GRPR and posterior cortical atrophy: Interestingly, trastuzumab, an anti-HER2 in combination with 177Lu-DOTAGA-PEG2-RM26, a GRPR TRT, has been shown to prolong overall survival in mice bearing the human PCa PC3 xenograft [63].